Delivery Order SPE2DB22D3016-SPE2DB23FBBC8
Award Date 5/8/23
Potential Completion Date 5/9/23
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,656.98, is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 24, 2023. It is not associated with a set-aside designation. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,871.58 firm fixed-price delivery order is for the supply of 120-count capsules of the drug Icosapent Ethyl 1 gram. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,105.76 firm fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules, with a completion date of September 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. The contract has a ceiling value of $1,468.09 and runs through February 2025. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) on May 9, 2025. The $1,217.70 firm fixed-price delivery order is for the supply of 4,568,201,904 units of the prescription medication Icosapent Ethyl 1 gram capsules in quantities of 120 per bottle. The award has an ultimate completion date of May 12, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $2,294.22, is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price delivery order. The award is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a significant supplier of medical...
- This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product, with a ceiling value of $1,315.75 and a performance period through June 6, 2025. This contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award is for the delivery of 120 count 1 gram capsules of Icosapent Ethyl, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,132.46, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 7, 2023. The contract has a final completion date of November 8, 2023 and is structured as a firm fixed-price delivery order. No set-aside designations were used for this award. Amerisourcebergen Drug Corp is a...
- This federal contract award, with an ID of SPE2DX15D3014|SPE2DX24FXCHH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,372.81, is for the delivery of Icosapent Ethyl 1 Gram Capsule 120s, a pharmaceutical product. The award is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB23FBBC8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S. The firm-fixed-price Delivery Order, valued at $1,138.43, has a completion date of May 9, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 5/9/25, 9:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/8/23 |